The Fanconi anemia core complex associates with chromatin during S phase

Blood

Volumn 105, Issue 2, 2005, Pages 759-766

  Mi, Jun ^a   Kupfer, Gary M ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MITOMYCIN C; PLASMID DNA;

ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL CYCLE; CELL CYCLE S PHASE; CHROMATIN; CONTROLLED STUDY; CROSS LINKING; DNA DAMAGE; FANCONI ANEMIA; FLUORESCENCE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 11244337035     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0001     Document Type: Article

References (53)

1. Alter BP, Young NS. The Bone Marrow Failure Syndromes. In: Nathan DG, Oski FA, eds. Hematology of infancy and childhood, vol 1. Philadelphia, PA: WB Saunders; 1993:216-316.
2. Auerbach A, Buchwald M, Joenje H. Fanconi Anemia. In: Vogelstein B, Kinzler K, eds. Genetics of cancer. New York, NY: McGraw-Hill; 1997:317-332.
3. Fanconi G. Familiar infantile perniziosaartige Anamie (pernizioses Blutbild und Konstitution). Z Kinderheil. 1927;117:257-280.
4. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi's anemia (FA), I: clinical aspects. Semin Hematol. 1967;4:233-240.
5. Joenje H, Oostra A, Wijker M, et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet. 1997;61:940-944.
6. Joenje H, Levitus M, Waisfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet. 2000;67:759-762.
7. Levitus M, Rooimans MA, Steltenpool J, et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood. 2004;103:2498-2503.
8. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992; 356:763-767.
9. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nat Genet. 1996; 14:320-323.
10. Apostolou S, Whitmore SA, Crawford J, et al. Positional cloning of the Fanconi Anaemia Group A gene. Nat Genet. 1996;14:324-328.
11. de Winter JP, Rooimans MA, van DerWeel L, et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24:15-16.
12. de Winter JP, Leveille F, van Berkel CG, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67:1306-1308.
13. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20:281-283.
14. Hejna JA, Timmers CD, Reifsteck C, et al. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3. Am J Hum Genet. 2000;66:1540-1551.
15. Whitney M, Thayer M, Reifsteck C, et al. Microcell mediated chromosome transfer maps the Fanconi anemia group D gene to chromosome 3p. Nat Genet. 1995;11:341-343.
16. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241-248.
17. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165-170.
18. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood. 1997; 90:974-985.
19. Whitney M, Royle G, Low M, et al. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 1996; 88:49-58.
20. Gumming RC, Liu JM, Youssoufian H, Buchwald M. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the MCgene. Blood. 1996;88:4558-4567.
21. Marathi UK, Howell SR, Ashmun RA, Brent TP. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. Blood. 1996;88:2298-2305.
22. Ridet A, Guillouf C, Duchaud E, et al. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 1997;57:1722-1730.
23. Kupfer GM, D'Andrea AD. The effect of the Fanconi Anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. Blood. 1996;88:1019-1025.
24. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet. 1982;62:327-332.
25. Kaiser TN, Lojewski A, Dougherty C, Juergens L, Sahar E, Latt SA. Flow cytometric characterization of the response of Fanconi's Anemia cells to mitomycin C treatment. Cytometry. 1982;2:291-297.
26. Haneline L, Broxmeyer H, Cooper S, et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from fac-/- mice. Blood. 1998;91:4092-4098.
27. Pang Q, Fagerlie S, Christianson TA, et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma Interferon and hematopoietic growth factors. Mol Cell Biol. 2000;20:4724-4735.
28. Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med. 2001;7:814-820.
29. Akkari YM, Bateman RL, Reifsteck CA, Olson SB, Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol Cell Biol. 2000;20:8283-8289.
30. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet. 1997;17:487-490.
31. Naf D, Kupfer GM, Suliman A, Lambert K, D'Andrea AD. Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol Cell Biol. 1998;18:5952-5960.
32. Yamashita T, Kupfer G, Naf D, et al. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci U S A. 1998;95:13085-13090.
33. Christianson TA, Bagby GC. FANCA protein binds FANCG proteins in an intracellular complex. Blood. 2000;95:725-726.
34. de Winter JP, van Der Weel L, de Groot J, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 2000;9:2665-2674.
35. Garcia-Higuera I, Kuang Y, Naf D, Wasik J, D'Andrea AD. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol. 1999;19:4866-4873.
36. Waisfisz Q, de Winter JP, Kruyt FA, et al. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci U S A. 1999;96:10320-10325.
37. Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet. 2003;12:2503-2510.
38. Thomashevski A, High AA, Drozd M, et al. The Fanconi anemia core complex forms 4 different sized complexes in different subcellular compartments. J Biol Chem. 2004;279:26201-26209.
39. Qiao F, Moss A, Kupfer GM. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J Biol Chem. 2001;276:23391-23396.
40. Meetei AR, Van Z, Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle. 2004;3:179-181.
41. Wang X, Andreassen PR, D'Andrea AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol. 2004;24:5850-5862.
42. Muchardt C, Reyes JC, Bourachot B, Leguoy E, Yaniv M. The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J. 1996;15:3394-3402.
43. Blower MD, Sullivan BA, Karpen GH. Conserved organization of centromeric chromatin in flies and humans. Dev Cell. 2002;2:319-330.
44. Nakanishi K, Moran A, Hays T, et al. Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9. Exp Hematol. 2001;29:842-849.
45. Kupfer G, Naf D, Garcia-Higuera I, et al. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. Exp Hematol. 1999;27:587-593.
46. Pichierri P, Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 2004; 23:1178-1187.
47. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 2002; 100:2414-2420.
48. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7:249-262.
49. Rothfuss A, Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol. 2004;24;123-134.
50. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol. 1999;69:3-12.
51. Otsuki T, Furukawa Y, Ikeda K, et al. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum Mol Genet. 2001;10:2651-2660.
52. Hewlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002;297:606-609.
53. Meetei AR, Sechi S, Wallisch M, et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol. 2003;23:3417-3426.